Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Khorashad JS"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Khorashad JS, Lavallade HD, Apperley JF, Milojkovic D, Reid AG, Bua M, Szydlo R, Olavarria E, Kaeda J, Goldman JM, Marin D
Publikováno v:
Journal of Clinical Oncology; 10/10/2008, Vol. 26 Issue 29, p4806-4813, 8p
Autor:
de Lavallade H, Apperley JF, Khorashad JS, Milojkovic D, Reid AG, Bua M, Szydlo R, Olavarria E, Kaeda J, Goldman JM, Marin D
Publikováno v:
Journal of Clinical Oncology; 7/10/2008, Vol. 26 Issue 20, p3358-3363, 6p
Autor:
Khorashad JS; Department of Immunology and inflammation, Imperial College London, London, W12 0NN, UK.; Department of Molecular Pathology, Institute of Cancer Research, Sutton, SM2 5PT, UK.; Department of Haematology, Division of Cancer & Genetics, School of Medicine, Cardiff University, Cardiff, CF14 4XN, UK., Rizzo S; Department of Haematology, Division of Cancer & Genetics, School of Medicine, Cardiff University, Cardiff, CF14 4XN, UK., Tonks A; Department of Haematology, Division of Cancer & Genetics, School of Medicine, Cardiff University, Cardiff, CF14 4XN, UK.
Publikováno v:
Cancer drug resistance (Alhambra, Calif.) [Cancer Drug Resist] 2024 Feb 22; Vol. 7, pp. 5. Date of Electronic Publication: 2024 Feb 22 (Print Publication: 2024).
Autor:
May PC; Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, UK.; Specialist Integrated Haematological Malignancy Service, Great Ormond Street Hospital for Children, NHS Foundation Trust, London, UK., Reid AG; North West Genomic Laboratory Hub, Manchester NHS Foundation Trust, Manchester, UK., Robinson ME; Center of Molecular and Cellular Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA., Khorashad JS; Clinical Genomics, The Centre for Molecular Pathology, The Royal Marsden NHS Foundation Trust, London, UK., Milojkovic D; Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, UK.; Department of Clinical Haematology, Imperial College Healthcare NHS Trust, London, UK., Claudiani S; Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, UK.; Department of Clinical Haematology, Imperial College Healthcare NHS Trust, London, UK., Willis F; Department of Haematology, St George's University NHS Foundation Trust, London, UK., Apperley JF; Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, UK.; Department of Clinical Haematology, Imperial College Healthcare NHS Trust, London, UK., Innes AJ; Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, UK. a.innes@imperial.ac.uk.; Department of Clinical Haematology, Imperial College Healthcare NHS Trust, London, UK. a.innes@imperial.ac.uk.
Publikováno v:
BMC medical genomics [BMC Med Genomics] 2023 Jul 26; Vol. 16 (1), pp. 172. Date of Electronic Publication: 2023 Jul 26.
Autor:
Zhao H; Versiti Blood Research Institute, Milwaukee, WI.; Medical College of Wisconsin, Milwaukee, WI.; Division of Hematology and Hematologic Malignancies and.; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT., Pomicter AD; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT., Eiring AM; Texas Tech University, El Paso, TX., Franzini A; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT., Ahmann J; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT., Hwang JY; Department of Oncological Sciences, The University of Utah, Salt Lake City, UT., Senina A; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT., Helton B; Department of Chemistry, University of Washington, Seattle, WA., Iyer S; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT., Yan D; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT., Khorashad JS; Department of Immunology and Inflammation, Imperial College London, London, United Kingdom., Zabriskie MS; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT., Agarwal A; Division of Hematology and Medical Oncology, Oregon Health & Science University Knight Cancer Institute, Portland, OR., Redwine HM; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT., Bowler AD; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT., Clair PM; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT., McWeeney SK; Division of Hematology and Medical Oncology, Oregon Health & Science University Knight Cancer Institute, Portland, OR., Druker BJ; Division of Hematology and Medical Oncology, Oregon Health & Science University Knight Cancer Institute, Portland, OR., Tyner JW; Division of Hematology and Medical Oncology, Oregon Health & Science University Knight Cancer Institute, Portland, OR., Stirewalt DL; Fred Hutchinson Cancer Research Center, Seattle, WA; and., Oehler VG; Fred Hutchinson Cancer Research Center, Seattle, WA; and., Varambally S; Department of Pathology, University of Alabama Birmingham, Birmingham, AL., Berrett KC; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT., Vahrenkamp JM; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT., Gertz J; Department of Oncological Sciences, The University of Utah, Salt Lake City, UT., Varley KE; Department of Oncological Sciences, The University of Utah, Salt Lake City, UT., Radich JP; Fred Hutchinson Cancer Research Center, Seattle, WA; and., Deininger MW; Versiti Blood Research Institute, Milwaukee, WI.; Medical College of Wisconsin, Milwaukee, WI.; Division of Hematology and Hematologic Malignancies and.; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT.
Publikováno v:
Blood [Blood] 2022 Feb 03; Vol. 139 (5), pp. 761-778.
Autor:
Bolandi SM; Department of Immunology, Razi Vaccine and Sera Research Institute, Karaj, Iran.; Department of Pharmacology, Karaj Branch, Islamic Azad University, Karaj, Iran., Pakjoo M; Department of Hematology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran., Beigi P; Department of Hematology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran., Kiani M; Department of Pharmacology, Karaj Branch, Islamic Azad University, Karaj, Iran., Allahgholipour A; Department of Pharmacology, Karaj Branch, Islamic Azad University, Karaj, Iran., Goudarzi N; Department of Immunology, Razi Vaccine and Sera Research Institute, Karaj, Iran., Khorashad JS; Centre for Haematology, Hammersmith Hospital, Imperial College London, London W12 0HS, UK., Eiring AM; Center of Emphasis in Cancer, Department of Molecular and Translational Medicine, Texas Tech University Health Sciences Center at El Paso, El Paso, TX 79905, USA.
Publikováno v:
Cells [Cells] 2021 Oct 21; Vol. 10 (11). Date of Electronic Publication: 2021 Oct 21.
Autor:
Ribeiro S; Centre for Molecular Pathology, Royal Marsden Hospital, Sutton SM2 5PT, UK., Eiring AM; Center of Emphasis in Cancer, Department of Molecular and Translational Medicine, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center at El Paso, El Paso, TX 79905, USA., Khorashad JS; Centre for Molecular Pathology, Royal Marsden Hospital, Sutton SM2 5PT, UK.; Division of Molecular Pathology, Institute of Cancer Research, Sutton SM2 5PT, UK.; Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London W12 0NN, UK.
Publikováno v:
Cancers [Cancers (Basel)] 2021 Oct 09; Vol. 13 (20). Date of Electronic Publication: 2021 Oct 09.
Autor:
Claudiani S; Centre for Haematology, Department of Immunology and Inflammation, Imperial College, London W12 0NN, UK., Mason CC; Department of Pediatrics, Division of Pediatric Hematology and Oncology, University of Utah, Salt Lake City, UT 84108, USA., Milojkovic D; Centre for Haematology, Department of Immunology and Inflammation, Imperial College, London W12 0NN, UK., Bianchi A; Department of Information Engineering, University of L'Aquila, 67100 L'Aquila, Italy., Pellegrini C; Department of Biotechnological and Applied Clinical Science, University of L'Aquila, 67100 L'Aquila, Italy., Di Marco A; Department of Information Engineering, University of L'Aquila, 67100 L'Aquila, Italy., Fiol CR; Centre for Haematology, Department of Immunology and Inflammation, Imperial College, London W12 0NN, UK., Robinson M; Centre for Haematology, Department of Immunology and Inflammation, Imperial College, London W12 0NN, UK., Ponnusamy K; Centre for Haematology, Department of Immunology and Inflammation, Imperial College, London W12 0NN, UK., Mokretar K; Centre for Haematology, Department of Immunology and Inflammation, Imperial College, London W12 0NN, UK., Chowdhury A; Centre for Haematology, Department of Immunology and Inflammation, Imperial College, London W12 0NN, UK., Albert M; Centre for Haematology, Department of Immunology and Inflammation, Imperial College, London W12 0NN, UK., Reid AG; Molecular Pathology Unit, Liverpool University, Liverpool L7 8XP, UK., Deininger MW; Versiti Blood Research Institute, Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI 53226, USA., Naresh K; Centre for Haematology, Department of Immunology and Inflammation, Imperial College, London W12 0NN, UK., Apperley JF; Centre for Haematology, Department of Immunology and Inflammation, Imperial College, London W12 0NN, UK., Khorashad JS; Centre for Haematology, Department of Immunology and Inflammation, Imperial College, London W12 0NN, UK.
Publikováno v:
Cancers [Cancers (Basel)] 2021 Sep 28; Vol. 13 (19). Date of Electronic Publication: 2021 Sep 28.